hmmm...
and still remain confident that finalisation of the PhIII trials in Q1 this year, closure of the Berlin Phama cluster* and SC revisiting the 'powers that be' in New York to say everythings cool, will significantly de-risk this stock.
am also interested in the potential aquisitions that their consultant might be looking at.
still cheap at this SP
bluebush
Add to My Watchlist
What is My Watchlist?